Clinical trials: Dysthymia
Major Depression, Dysthymia
Dichotic Listening as a Predictor of Medication Response in Depression
Depressed patients will have hearing tests and then be treated with up to three treatments (i.e., Fluoxetine, Imipramine) until remitted, to see whether test results predict specific outcomes.
- Conditions
- Major Depression, Dysthymia, Depressive Disorder Not Otherwise Specified
- Trial name
- NCT00296725
- Testing
- Fluoxetine, Imipramine
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- New York State Psychiatric Institute
Major Depression, Dysthymia
Implementation of Harmonized Depression Outcome Measures in a Health System
Working with a health system, the investigators will recruit practices to participate in the pilot study, consent and enroll patients with major depressive disorder, and collect the PHQ-9 from those patients at three timepoints…
- Trial name
- NCT04235712
- Testing
- Harmonized Depression Outcome Measures
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- OM1, Inc.
Major Depression, Mania
Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
The primary aims of this study are to assess: 1. The inter-rater and test-retest reliability of the MINI-KID 2. The validity of the standard MINI-KID interview in relation to the parent rated pencil/paper version (MINI-KID-P) and…
- Conditions
- Major Depression, Mania, Anxiety Disorders, Psychotic Disorder
- Trial name
- NCT00579267
- Testing
- MINI-KID
- Where
- United States
- Volunteers
- 230 people, healthy volunteers welcome
- Sponsor
- University of South Florida
Dysthymic Disorder, Depressive Disorder NOS
Duloxetine for Chronic Depression: a Double-blind Study
The investigators are studying a new antidepressant medicine, duloxetine, for the treatment of people with chronic depression. Duloxetine (trade name Cymbalta) was recently approved by the FDA for the treatment of major…
- Trial name
- NCT00360724
- Testing
- Duloxetine (Cymbalta)
- Where
- United States
- Volunteers
- 65 people
- Sponsor
- New York State Psychiatric Institute
Depression, Major Depressive Disorder
eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk
This pilot randomized controlled trial seeks: (1) to determine the preliminary efficacy of our modernized collaborative care intervention for depression in improving the diabetes risk markers of hemoglobin A1c and insulin…
- Conditions
- Depression, Major Depressive Disorder, Dysthymic Disorder, Depressive Symptoms
- Trial name
- NCT04437485
- Testing
- Good Days Ahead (GDA), Problem Solving Treatment in Primary Care (PST-PC), Antidepressant Medications
- Where
- United States
- Volunteers
- 46 people
- Sponsor
- Indiana University
Major Depressive Disorder, Dysthymic Disorder
The Efficacy of Parent Involvement in the Treatment of Adolescent Depression
The primary aim of this study is to examine whether adolescent depression and the family context in which it develops is best treated using an individual adolescent intervention or an intervention that includes both the…
- Conditions
- Major Depressive Disorder, Dysthymic Disorder, Depressive Disorder NOS, Adjustment Disorder
- Trial name
- NCT00883519
- Testing
- Interpersonal Psychotherapy for Depressed Adolescents, Interpersonal Psychotherapy for Depressed Adolescents and Parents
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- New York State Psychiatric Institute
Major Depressive Disorder, Dysthymic Disorder
Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults
The goal of this open-administration treatment study of citalopram (or duloxetine) is to evaluate the effect of antidepressant medication on treating the syndrome of "frailty" in older adults with depressive symptoms.
- Conditions
- Major Depressive Disorder, Dysthymic Disorder, Depressive Disorder, NOS
- Trial name
- NCT01973283
- Testing
- Antidepressant Medication
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- New York State Psychiatric Institute
Chronic Depressive Disorder, Dysthymic Disorder
Schema Therapy for Chronic Depression
To compare the efficacy of schema therapy versus active monitoring for women with chronic depression receiving psychiatric care.
- Trial name
- NCT03084744
- Testing
- Schema therapy, Active monitoring
- Where
- Japan
- Volunteers
- 64 people
- Sponsor
- Institute for Health Economics and Policy, Japan
Dysthymic Disorder
Wellbutrin XL for Dysthymic Disorder
This is a ten-week, double-blind study of Wellbutrin XL in outpatients with dysthymic disorder, a form of low-grade chronic depression.
- Trial name
- NCT00225251
- Testing
- bupropion XL
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- St. Luke's-Roosevelt Hospital Center
Depression, Dysthymic Disorder
Internet-delivered Transdiagnostic Intervention for Anxiety and Depression
Objectives 1. To test the effectiveness and acceptability of an augmented internet-supported transdiagnostic intervention in Romania. 2.
- Conditions
- Depression, Dysthymic Disorder, Panic Disorder, Social Phobia
- Trial name
- iTAD (NCT02739607)
- Testing
- Transdiagnostic program
- Where
- Romania
- Volunteers
- 100 people
- Sponsor
- West University of Timisoara
Substance Abuse, Substance Dependence
Group Therapy for Women Prisoners With Comorbid Substance Use and Depression
The purpose of the study is to determine whether interpersonal psychotherapy is effective for treating co-occurring depression and substance use among women prisoners.
- Conditions
- Substance Abuse, Substance Dependence, Depressive Disorder
- Trial name
- NCT00606996
- Testing
- Group interpersonal psychotherapy (IPT-G), Psychoeducation on co-occurring disorders (PSYCHOED)
- Where
- United States
- Volunteers
- 38 people
- Sponsor
- Brown University
Depression, Dysthymic Disorder
Duloxetine Treatment in Elderly With Dysthymia
Dysthymic disorder (DD) denotes chronic depression with fewer symptoms than major depressive disorder (MDD), and it affects ~ 2-4 % of adults with a similar prevalence in the elderly.
- Trial name
- NCT01852383
- Testing
- Duloxetine
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- New York State Psychiatric Institute
Atypical Depression
A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression
This is a Pilot Study to get a first indication whether Duloxetine may be effective for depressed patients with Atypical Features.
- Trial name
- NCT00296699
- Testing
- Duloxetine
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- New York State Psychiatric Institute
Depression, Mild Cognitive Impairment
Combination Treatment Study for Memory Impairment and Depression
Patients presenting with depression (DEP) and cognitive impairment (CI), represent a unique, understudied population that is difficult to diagnose, treat and estimate prognosis.
- Trial name
- DEP-CI (NCT01658228)
- Testing
- Donepezil, Citalopram, Venlafaxine
- Where
- 2 sites in United States
- Volunteers
- 86 people
- Sponsor
- New York State Psychiatric Institute
Major Depressive Disorder, Bipolar Disorder
Using Mental Health Telemetry to Predict Relapse and Re-hospitalization in Mood Disorders
Mood disorders -- major depression, bipolar disorder, and dysthymia -- frequently recur; they affect one in four people during their lives. At Sunnybrook, 75% of inpatient admissions are due to mood disorders.
- Conditions
- Major Depressive Disorder, Bipolar Disorder, Dysthymia
- Trial name
- PATH-MOD (NCT01882608)
- Testing
- Mental Health Telemetry (MHT)
- Where
- Canada
- Volunteers
- 33 people
- Sponsor
- Dr. David Kreindler
Depression
Can E-therapies Reduce Waiting Lists in Secondary Mental Health Care? A Randomized Controlled Trial
Depression is common and disabling but access to specialist treatment is often delayed with waiting lists of up to a year not uncommon.
- Trial name
- NCT02423733
- Testing
- The Journal
- Where
- Canada
- Volunteers
- 110 people
- Sponsor
- University of Ottawa
Major Depressive Disorder, Dysthymia
Project to Improve Symptoms and Mood in People With Spinal Cord Injury
Depression is likely the most prevalent and disabling psychological complication associated with spinal cord injury (SCI). Yet no controlled depression treatment trials have been performed in this population.
- Conditions
- Major Depressive Disorder, Dysthymia, Spinal Cord Injuries
- Trial name
- PRISMS (NCT00592384)
- Testing
- venlafaxine XR
- Where
- 6 sites in United States
- Volunteers
- 133 people
- Sponsor
- University of Washington
Cardiovascular Diseases, Diabetes Mellitus, Type 2
Motivational Interviewing and Cognitive Behavioral Therapy-based Intervention for Cardiovascular Disease Prevention Amongst American Indians With Diabetic and Depressive Symptoms
American Indians (AIs) living in the Northwest have very high rates of diabetes, obesity, tobacco use, depression, and other risk factors associated with cardiovascular disease.
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Type 2, Depression, Dysthymic Disorder
- Trial name
- NCT01892124
- Testing
- Motivational Interviewing/Cognitive Behavioral-based Therapy
- Where
- United States
- Volunteers
- 34 people
- Sponsor
- University of Washington
Bipolar Disorder, Mood Disorders
Characterizing MyMood Patterns of Use
MyMood is an electronic mood-charting tool available to the general population of Sunnybrook Health Sciences Centre (SHSC). This project aims to characterize duration and frequency of use of MyMood by users characteristics and…
- Conditions
- Bipolar Disorder, Mood Disorders, Depression, Dysthymia
- Trial name
- NCT04664374
- Testing
- MyMood
- Where
- Canada
- Volunteers
- 400 people
- Sponsor
- Sunnybrook Health Sciences Centre
Major Depressive Disorder, Dysthymic Disorder
Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression
The primary aim of this study is to test the feasibility and efficacy of Mindfulness Based Cognitive Therapy (MBCT) training for the treatment of depressive symptoms in patients with chronic pain.
- Conditions
- Major Depressive Disorder, Dysthymic Disorder, Depressive Disorder NOS, Chronic Pain
- Trial name
- NCT01473615
- Testing
- Mindfulness Based Cognitive Therapy
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Massachusetts General Hospital